Acute Myeloid Leukemia Is a Disease Associated with HLA-C3

Publisher： Karger

E-ISSN： 1421-9662|133|2|164-167

ISSN： 0001-5792

Source： Acta Haematologica, Vol.133, Iss.2, 2014-09, pp. : 164-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pityriasis rotunda associated with acute myeloid leukemia

By  

THE JOURNAL OF DERMATOLOGY, Vol. 45, Iss. 1, 2018-01 ,pp. : 105-106

John Wiley & Sons Inc

Access to resources Recommend Favorite

Minimal residual disease as biomarker for optimal biologic dosing of ARA‐C in patients with acute myeloid leukemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 2, 2015-02 ,pp. : 125-131

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment with FLT3 inhibitor in patients with FLT3‐mutated acute myeloid leukemia is associated with development of secondary FLT3–tyrosine kinase domain mutations

By  

CANCER, Vol. 120, Iss. 14, 2014-07 ,pp. : 2142-2149

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immunotherapy in acute myeloid leukemia

By  

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2689-2704

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapy-Related Acute Myeloid Leukemia in Crohn’s Disease

By  

Acta Haematologica, Vol. 129, Iss. 1, 2012-09 ,pp. : 20-22

Karger

Access to resources Recommend Favorite